Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE4
Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3
- Status
- COMPLETED
- Phase
- PHASE2
Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Population Study on Candidemia in Spain
- Status
- COMPLETED
- Phase
- N/A
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
- Status
- COMPLETED
- Phase
- PHASE4
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL
- Status
- TERMINATED
- Phase
- PHASE2
A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE1
Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- PHASE3
Ranolazine and Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- PHASE3